A Speedinvest portfolio company

Molecule

Year Invested
2022
Molecule's open platform connects life science research to funding.

Molecule is creating collaborative ecosystems, where stakeholders in drug development can work together to expedite the process of bringing novel therapeutics to patients. They are connecting leading researchers to funding by turning intellectual property and its development into a liquid and easily investable asset.

https://www.molecule.to/
Hi, we're Speedinvest

Proud partners with Europe's most visionary founders who are redefining technology's role in our daily lives.

Tell us about your startup